Prothena Corporation plc
PRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $135,157 | $91,370 | $53,905 | $200,577 |
| % Growth | 47.9% | 69.5% | -73.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $135,157 | $91,370 | $53,905 | $200,577 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $222,519 | $220,571 | $135,562 | $82,284 |
| G&A Expenses | $67,199 | $61,835 | $49,900 | $46,318 |
| SG&A Expenses | $67,199 | $61,835 | $49,900 | $46,318 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $289,718 | $282,406 | $185,462 | $128,602 |
| Operating Income | -$154,561 | -$191,036 | -$131,557 | $71,975 |
| % Margin | -114.4% | -209.1% | -244.1% | 35.9% |
| Other Income/Exp. Net | $25,631 | $30,556 | $5,952 | -$54 |
| Pre-Tax Income | -$128,930 | -$160,480 | -$125,605 | $71,921 |
| Tax Expense | -$6,620 | -$13,452 | -$8,656 | $4,946 |
| Net Income | -$122,310 | -$147,028 | -$116,949 | $66,975 |
| % Margin | -90.5% | -160.9% | -217% | 33.4% |
| EPS | -2.27 | -2.76 | -2.47 | 1.51 |
| % Growth | 17.8% | -11.7% | -263.6% | – |
| EPS Diluted | -2.27 | -2.76 | -2.47 | 1.38 |
| Weighted Avg Shares Out | 53,772 | 53,216 | 47,369 | 44,228 |
| Weighted Avg Shares Out Dil | 53,772 | 53,216 | 47,369 | 48,464 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25,816 | $31,014 | $6,349 | $42 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $893 | $928 | $744 | $1,115 |
| EBITDA | -$153,668 | -$190,108 | -$130,813 | $73,090 |
| % Margin | -113.7% | -208.1% | -242.7% | 36.4% |